Document Detail

Nebulized amphotericin B combined with intravenous amphotericin B in rats with severe invasive pulmonary aspergillosis.
MedLine Citation:
PMID:  16641459     Owner:  NLM     Status:  MEDLINE    
Nebulized amphotericin B (AMB) combined with intravenous AMB was studied in persistently leukopenic rats with invasive pulmonary aspergillosis. Pulmonary concentrations of AMB after aerosol treatment were substantially higher than after intravenous liposomal AMB. Nebulized liposomal AMB in addition to intravenous AMB resulted in significantly prolonged survival compared to controls.
Elisabeth J Ruijgrok; Marcel H A M Fens; Irma A J M Bakker-Woudenberg; Els W M van Etten; Arnold G Vulto
Related Documents :
6229069 - Spontaneous long-term acceptance of rt-1-incompatible liver allografts in inbred rats. ...
8179379 - Donor-specific immune response after aortic valve allografting in the rat.
3278439 - Characteristics of rejection of orthotopic corneal allografts in the rat.
132419 - Direct fick application for measurement of cardiac output in rat.
17700169 - Nitrosative stress and corneal transplant endothelial cell death during acute graft rej...
16564709 - The influence of cryopreservation on changes in diameter and compliance of allografts i...
21769959 - Axonal tracing of the normal and regenerating visual pathway of mouse, rat, frog, and f...
1720829 - Heart failure augments the cardiovascular and renal effects of neutral endopeptidase in...
4333849 - The development of gluconeogenesis in rat liver. controlling factors in the newborn.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Antimicrobial agents and chemotherapy     Volume:  50     ISSN:  0066-4804     ISO Abbreviation:  Antimicrob. Agents Chemother.     Publication Date:  2006 May 
Date Detail:
Created Date:  2006-04-27     Completed Date:  2006-06-09     Revised Date:  2013-06-07    
Medline Journal Info:
Nlm Unique ID:  0315061     Medline TA:  Antimicrob Agents Chemother     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1852-4     Citation Subset:  IM    
Department of Clinical Pharmacy, Medical Center Rijnmond-Zuid, Olympiaweg 350, 3078 HT Rotterdam, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Amphotericin B / administration & dosage*,  pharmacology
Antifungal Agents / administration & dosage*,  pharmacology
Aspergillosis / drug therapy*
Aspergillus fumigatus / drug effects*
Biological Markers / metabolism
Injections, Intravenous
Lung Diseases, Fungal / drug therapy*,  microbiology
Nebulizers and Vaporizers / microbiology
Severity of Illness Index
Treatment Outcome
Reg. No./Substance:
0/Antifungal Agents; 0/Biological Markers; 0/Liposomes; 1397-89-3/Amphotericin B

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Functional characterization and target validation of alternative complex I of Plasmodium falciparum ...
Next Document:  Streptococcus pneumoniae isolates resistant to telithromycin.